• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • MRI Images
  • Sample Access
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

EPAD trial delivery centres

The EPAD Longitudinal Cohort Study is not longer recruiting and following up participants. We recruited research participants from centres across Europe.

Scotland / Ireland

University of Edinburgh

NHS Tayside, Dundee

NHS Glasgow

NHS Grampian

England / Wales

University of Oxford

WLMHT, London

GM:CRN, Manchester

University of Cambridge

NBT, Bristol

Sheffield

France

CHUT, Toulouse

CHUN, Nantes

CHRU, Lille

Paris Lariboisiere (Paris Nord)

Montpellier

Paris La Salpetriere

Spain / Greece

BBRC, Barcelona

CITA, San Sebastian

Fundacio ACE, Barcelona

Aeginition Hospital Athens

Santander

Hospital Clinic de Barcelona

Benelux

VUmc, Amsterdam

Brussels CUSL

Nordics

KI, Sweden

Gothenburg, Sweden

Switzerland/Italy

HUG, Geneva

IRCCS – Fatebenefratelli, Brescia

Perugia, Italy

Lausanne, Switzerland

 

Share this page
FacebookTwitterLinkedInGoogle+
Latest News
  • Bruno Steinkraus
    Interview with Dr. Bruno Steinkraus, Chief Scientific Officer at Hummingbird Diagnostics GmbH
    2022-11-25
  • New paper defining and discussing the substantial assets of the EPAD project is out!
    2022-11-23
  • New paper using the EPAD data for an analysis of sleep quality and efficiency
    2022-11-03
  • New paper evaluating diabetes in the EPAD Study published in EJN
    2022-10-03
  • Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the EPAD LCS
    2022-09-01
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

Researchers from @cogsleep @HBAProgram_USYD used @IMI_EPAD data to determine the association between sleep quality and #Alzheimer's disease biomarkers. Congratulations to the authors @Prof_Naismith @YueLengsleep @BrendanLucey_MD👏 ⬇️ alz-journals.onlinelibrary.wi…

reply retweet favorite
8:15 am · 2022-11-28
Twitter
EPAD
EPAD
@IMI_EPAD

Our @IMI_EPAD samples can be requested for use in #Alzheimer’s #prevention #research. For more information on how to access the EPAD samples, please visit our website⤵️ ep-ad.org/samples-access/ pic.twitter.com/48EIH7Yhpc

reply retweet favorite
8:30 am · 2022-11-25
Twitter
EPAD
EPAD
@IMI_EPAD

Hummingbird Diagnostics has begun to analyse the @IMI_EPAD data. Dr. Bruno Steinkraus will share a first glimpse of these interesting results at the @CTADconference #CTAD22 next week! ➡️Come by and see him at Poster LP48: “Early Detection of Alzheimer’s Disease using microRNAs” pic.twitter.com/XPF0Twf97J

reply retweet favorite
8:20 am · 2022-11-25
Twitter
EPAD
EPAD
@IMI_EPAD

We successfully sent samples collected annually from research participants throughout their participation in the @IMI_EPAD study for RNA analyses to Hummingbird Diagnostics. We caught up with Dr. Bruno Steinkraus (CSO) to learn more about his work⬇️ ep-ad.org/interview-with… pic.twitter.com/lXI76pItgK

reply retweet favorite
8:00 am · 2022-11-25
Twitter
EPAD
EPAD
@IMI_EPAD

Have a look on the @imi_epnd Cohort Catalogue including over 60 cohorts with metadata on participants, bio samples, imaging and cognitive data such as the @IMI_EPAD Longitudinal Cohort Study (@amsterdamumc participants) ⬇️ twitter.com/imi_epnd/statu…

reply retweet favorite
8:18 am · 2022-11-24
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT